Literature DB >> 27473286

Altered tryptophan metabolism in human meningioma.

Noble Kumar Talari1, Manas Panigrahi2, Sailaja Madigubba2, Sundaram Challa3, Prakash Babu Phanithi4.   

Abstract

Meningiomas are the neoplasms that arise from the arachnoid cells of the meninges. It was reported that cancer cells escape from immune system through the metabolism of an aromatic essential amino acid tryptophan (TRP) via Kynurenine (KYN) pathway. However, the role of TRP metabolites such as, 5-Hydroxy tryptophan (5-HTP), 5-Hydroxy tryptamine (5-HT), N-acetyl serotonin (NAS), Melatonin (MEL), KYN, N-acetyl tryptamine, 5-Hydroxy indole acetic acid (5-HIAA) and 5-Methoxy indole acetic acid is not yet evaluated in human meningioma. Therefore, in the current study we have evaluated the levels of TRP and its metabolites in the progression of human meningioma using tumor biopsy samples and autopsy control meninges with Reverse Phase-HPLC. We here report that TRP metabolism favors towards KYN pathway in human meningioma and it could be due to increased indoleamine 2,3-dioxygenase 2 levels as we found its m-RNA levels to be up regulated in human meningioma. We observed significant increase in KYN and 5HIAA levels and significant decrease in TRP, 5-HTP, 5-HT, NAS and MEL levels in meningioma compared to control meninges. Since TRP metabolites regulate inducible nitric oxide synthase (INOS) gene expression and thereby nitric oxide (NO) production, we have also evaluated the INOS and NO levels. The INOS and NO levels were up regulated in human meningioma. The present data corroborates with existing data on TRP metabolism in tumor progression and may serve to target TRP metabolism as a therapeutic intervention.

Entities:  

Keywords:  IDO; Kynurenine; Meningioma; Serotonin; Tryptophan

Mesh:

Substances:

Year:  2016        PMID: 27473286     DOI: 10.1007/s11060-016-2225-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Authors:  Alexander J Muller; James B DuHadaway; P Scott Donover; Erika Sutanto-Ward; George C Prendergast
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

2.  Selective expression of inducible nitric oxide synthase in human prostate carcinoma.

Authors:  T Klotz; W Bloch; C Volberg; U Engelmann; K Addicks
Journal:  Cancer       Date:  1998-05-15       Impact factor: 6.860

3.  Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue.

Authors:  M Kojima; T Morisaki; Y Tsukahara; A Uchiyama; Y Matsunari; R Mibu; M Tanaka
Journal:  J Surg Oncol       Date:  1999-04       Impact factor: 3.454

4.  Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.

Authors:  Juan C Mayo; Rosa M Sainz; Dun-Xian Tan; Rüdiger Hardeland; Josefa Leon; Carmen Rodriguez; Russel J Reiter
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

5.  Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.

Authors:  Edit Bosnyák; David O Kamson; Anthony R Guastella; Kaushik Varadarajan; Natasha L Robinette; William J Kupsky; Otto Muzik; Sharon K Michelhaugh; Sandeep Mittal; Csaba Juhász
Journal:  Neuro Oncol       Date:  2015-06-18       Impact factor: 12.300

6.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

7.  Cancer: Why tumours eat tryptophan.

Authors:  George C Prendergast
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

8.  Prevention of allogeneic fetal rejection by tryptophan catabolism.

Authors:  D H Munn; M Zhou; J T Attwood; I Bondarev; S J Conway; B Marshall; C Brown; A L Mellor
Journal:  Science       Date:  1998-08-21       Impact factor: 47.728

9.  Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid.

Authors:  G Melillo; G W Cox; A Biragyn; L A Sheffler; L Varesio
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

Review 10.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

View more
  6 in total

1.  Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.

Authors:  Noble Kumar Talari; Manas K Panigrahi; Sailaja Madigubba; Prakash Babu Phanithi
Journal:  J Neurooncol       Date:  2018-01-04       Impact factor: 4.130

2.  Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.

Authors:  Shuyu Hao; Guanyou Huang; Jie Feng; Da Li; Ke Wang; Liang Wang; Zhen Wu; Hong Wan; Liwei Zhang; Junting Zhang
Journal:  J Neurooncol       Date:  2019-06-08       Impact factor: 4.130

3.  Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.

Authors:  Anthony R Guastella; Sharon K Michelhaugh; Neil V Klinger; Hassan A Fadel; Sam Kiousis; Rouba Ali-Fehmi; William J Kupsky; Csaba Juhász; Sandeep Mittal
Journal:  J Neurooncol       Date:  2018-04-17       Impact factor: 4.130

4.  Tryptophan catabolism in epithelial ovarian carcinoma.

Authors:  Lynelle P Smith; Benjamin G Bitler; Jennifer K Richer; Jessica L Christenson
Journal:  Trends Cancer Res       Date:  2019

Review 5.  The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors.

Authors:  Maria L Perepechaeva; Alevtina Y Grishanova
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

6.  Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.

Authors:  Bongyong Lee; Iqbal Mahmud; Rudramani Pokhrel; Rabi Murad; Menglang Yuan; Stacie Stapleton; Chetan Bettegowda; George Jallo; Charles G Eberhart; Timothy Garrett; Ranjan J Perera
Journal:  Acta Neuropathol Commun       Date:  2022-02-24       Impact factor: 7.578

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.